Outlook Therapeutics, Inc. Business Finance Contracts & Agreements
77 Contracts & Agreements
- Exchange Agreements (3 contracts)
- Investor Rights Agreements (9)
- Note Agreements (11)
- Purchase Agreements (14)
- Registration Rights Agreements (4)
- Security Agreements (1)
- Stock Agreements (3)
- Term Sheets (1)
- Underwriting Agreements (6)
- Warrant Agreements (25)
- Third Amendment to Convertible Promissory Note, dated January 22, 2024 (Filed With SEC on January 24, 2024)
- Syntone Registration Rights Agreement, dated January 22, 2024 (Filed With SEC on January 24, 2024)
- Syntone Purchase Agreement, dated January 22, 2024 (Filed With SEC on January 24, 2024)
- Form of Registration Rights Agreement (Filed With SEC on January 24, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 24, 2024)
- Form of Syntone Warrant (Filed With SEC on January 24, 2024)
- Form of Warrant (Filed With SEC on January 24, 2024)
- Amendment, dated December 21, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC (Filed With SEC on December 22, 2023)
- Amendment, dated February 10, 2023, to the Convertible Promissory Note, dated December 22, 2022, by and between the Company and Streeterville Capital, LLC (Filed With SEC on February 14, 2023)
- Form of Securities Purchase Agreement, dated as of December 23, 2022, by and between the Company and the Purchasers (Filed With SEC on December 23, 2022)
- Form of Warrant (Filed With SEC on December 23, 2022)
- Form of Note (Filed With SEC on December 22, 2022)
- Securities Purchase Agreement, dated as of December 22, 2022, by and between the Company and Streeterville Capital, LLC (Filed With SEC on December 22, 2022)
- Amended and Restated Investor Rights Agreement, dated April 21, 2022, by and between Outlook Therapeutics, Inc. and GMS Ventures and Investments (Filed With SEC on April 22, 2022)
- Form of Underwriter Warrant (Filed With SEC on November 29, 2021)
- Amended and Restated Underwriting Agreement, dated November 23, 2021, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on November 29, 2021)
- Note Amendment dated November 16, 2021 (Filed With SEC on November 16, 2021)
- Promissory Note dated November 16, 2021 (Filed With SEC on November 16, 2021)
- Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 16, 2021 (Filed With SEC on November 16, 2021)
- Securities Purchase Agreement, dated February 9, 2021, by and between the Company and GMS Ventures and Investments (Filed With SEC on February 11, 2021)
- Securities Purchase Agreement, dated January 28, 2021, by and between the Company and Syntone Ventures LLC (Filed With SEC on February 2, 2021)
- Underwriting Agreement, dated January 28, 2021, by and between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on February 2, 2021)
- Promissory Note dated November 4, 2020 (Filed With SEC on November 6, 2020)
- Note Purchase Agreement between the Company and Streeterville Capital, LLC, dated as of November 4, 2020 (Filed With SEC on November 6, 2020)
- Securities Purchase Agreement, dated June 22, 2020, by and between the Company and Syntone Ventures LLC (Filed With SEC on June 23, 2020)
- Form of Securities Purchase Agreement, dated June 22, 2020, by and among the Company and the purchasers named therein (Filed With SEC on June 23, 2020)
- Form of Placement Agent Warrant (Filed With SEC on June 23, 2020)
- Stock Purchase Agreement, dated May 22, 2020, by and between the Company and Syntone Ventures LLC (Filed With SEC on May 28, 2020)
- Fourth Amendment to Investor Rights Agreement dated September 11, 2017 by and between the Company and BioLexis Pte. Ltd. (formerly GMS Tenshi Holdings Pte. Limited), by and... (Filed With SEC on February 24, 2020)
- Securities Purchase Agreement by and between the Company and GMS Ventures and Investments dated February 24, 2020 (Filed With SEC on February 24, 2020)
- Form of Securities Purchase Agreement, dated February 24, 2020, by and among the Company and the purchasers named therein (Filed With SEC on February 24, 2020)
- Form of Placement Agent Warrant (Filed With SEC on February 24, 2020)
- Form of GMS Stock Purchase Warrant (Filed With SEC on February 24, 2020)
- Form of Common Stock Purchase Warrant (Filed With SEC on February 24, 2020)
- Amendment to Warrants to Purchase Common Stock between the Company and BioLexis Pte. Ltd., dated as of January 27, 2020 (Filed With SEC on January 31, 2020)
- Amendment #2 dated December 23, 2019 of Warrant Agreement between the Company and American Stock Transfer & Trust Company LLC, as warrant agent, dated as of April 12, 2019, as... (Filed With SEC on December 23, 2019)
- Form of Senior Secured Promissory Note (Filed With SEC on December 23, 2019)
- Exchange Agreement dated December 23, 2019 (Filed With SEC on December 23, 2019)
- Third Note Amendment dated June 28, 2019 (Filed With SEC on July 1, 2019)
- Amendment #1 dated June 11, 2019 of Warrant Agreement between the Company and American Stock Transfer & Trust Company LLC, as warrant agent, dated as of April 12, 2019 (Filed With SEC on June 14, 2019)
